Biologic patent protection in the U.S. blocks biosimilars for 12 years after approval, delaying affordable alternatives. Learn how exclusivity rules, patent thickets, and high development costs keep prices high-and who’s paying the price.
Bringing a caregiver or advocate to medication appointments reduces errors, improves understanding, and ensures safety. Learn how to prepare, what to ask, and how to handle resistance from providers.
Soluble fiber helps control weight by reducing hunger and slowing digestion, while insoluble fiber supports gut health. Learn which types work best, how to use them, and why whole foods beat supplements.
Fluoxetine and paroxetine block the enzyme needed to turn codeine into morphine, making pain relief impossible. Learn why this interaction happens, which opioids still work, and what to ask your doctor.
Obesity changes how drugs move through the body, making standard doses ineffective or dangerous. Learn how lean body weight, adjusted dosing, and therapeutic monitoring can prevent treatment failure and toxicity.
Simple lifestyle changes like walking, eating better, and sleeping more can reduce medication risks and even lower your pill count. Backed by science, these habits help manage chronic conditions without replacing your meds - just supporting them.
Next-generation GLP-1 agents like retatrutide and orforglipron offer powerful weight loss but come with persistent GI side effects and emerging long-term safety concerns. Learn what’s known - and what’s still unknown.
Tall-man lettering uses capital letters to highlight differences in similar-looking drug names, helping prevent dangerous medication errors in hospitals and pharmacies. Learn how it works, where it's used, and why it still matters.
Ascites from cirrhosis requires careful management with sodium control and diuretics. Learn the latest evidence on how much salt to eat, which medications work best, and what to avoid to prevent complications.
The 180-day exclusivity rule was meant to reward generic drug makers for challenging patents. But brand-name companies can legally launch their own versions - called authorized generics - during that window, undercutting profits and undermining the system’s purpose.
© 2025. All rights reserved.